These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34017375)

  • 1. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
    Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
    Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular mechanism of kinesin family member 2A (KIF2A) underlying non-small cell lung cancer: the effect of its knockdown on malignant behaviors, stemness, chemosensitivity, and potential regulated signaling pathways.
    Chen J; Wen J; Liu D; Xu X; Fan M; Zhang Z
    Am J Transl Res; 2022; 14(1):68-85. PubMed ID: 35173830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients.
    Wang G; Wang Z; Yu H
    J Clin Lab Anal; 2020 Apr; 34(4):e23135. PubMed ID: 31858647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
    Liang X; Xia R
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting transient receptor potential canonical 1 reduces non‑small cell lung cancer chemoresistance and stemness via inhibition of PI3K/AKT signaling.
    Jin J; Yan X; Zhao Y; Zhang H; Zhuang K; Wen Y; He J; Gao J
    Oncol Lett; 2023 Jun; 25(6):224. PubMed ID: 37153044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosa‑associated lymphoid tissue lymphoma translocation protein 1 inhibitor, MI‑2, attenuates non‑small cell lung cancer cell proliferation, migration and invasion, and promotes apoptosis by suppressing the JNK/c‑JUN pathway.
    Wu C; Ge W; Wu Y
    Oncol Lett; 2024 Oct; 28(4):465. PubMed ID: 39119234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
    Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
    Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIF2A promotes the progression via AKT signaling pathway and is upregulated by transcription factor ETV4 in human gastric cancer.
    Zhang X; Wang Y; Liu X; Zhao A; Yang Z; Kong F; Sun L; Yu Y; Jiang L
    Biomed Pharmacother; 2020 May; 125():109840. PubMed ID: 32106376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF2BP1 facilitates non-small cell lung cancer progression by regulating the KIF2A-mediated Wnt/β-catenin pathway.
    Sun M; Wang L; Ge L; Xu D; Zhang R
    Funct Integr Genomics; 2023 Dec; 24(1):4. PubMed ID: 38102458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of BRAF-mediated PI3K/Akt/mTOR pathway on biological characteristics and chemosensitivity of NSCLC A549/DDP cells.
    Ren B; Liu H; Yang Y; Lian Y
    Oncol Lett; 2021 Aug; 22(2):584. PubMed ID: 34122635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer.
    Xia D; Chen B; Yang X
    J Clin Lab Anal; 2019 Oct; 33(8):e22973. PubMed ID: 31418948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinesin family member 2A links with advanced tumor stage, reduced chemosensitivity and worse prognosis in gastric cancer.
    Bai F; He Z; Zhou H; Gan W
    J Clin Lab Anal; 2022 May; 36(5):e24313. PubMed ID: 35313389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium Danshensu inhibits the progression of lung cancer by regulating PI3K/Akt signaling pathway.
    Wang M; Tang W; Gong N; Liu P
    Drug Dev Res; 2022 Feb; 83(1):88-96. PubMed ID: 34196024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA La-related protein 4 inhibits cell proliferation, migration, and invasion and sponges microRNA-367 in non-small cell lung cancer.
    Wang Y; Zhu J; Li X; Xu J; Xin Y; Liu Y
    Int J Clin Exp Pathol; 2021; 14(8):858-865. PubMed ID: 34527128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA SMARCA5 may serve as a tumor suppressor in non-small cell lung cancer.
    Tong S
    J Clin Lab Anal; 2020 May; 34(5):e23195. PubMed ID: 31944395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole Alters the Stem Cell Characteristics of A549 and NCI-H460 Human Lung Cancer Cells by Suppressing Wnt Signaling.
    Chen C; Zhang W
    Med Sci Monit; 2019 Dec; 25():9509-9516. PubMed ID: 31833479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.